Huihe Healthcare

Huihe Healthcare

汇禾医疗

Huihe Healthcare

Biotech/Healthcare

Since entering the structural heart disease field in 2018, Huihe Medical's first product, K-Clip™ (a transcatheter tricuspid annuloplasty system), has successfully completed its first-in-human humanitarian clinical trial and entered the confirmatory multicenter clinical trial stage. As it continues…

Latest round: Series C (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-12-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.